Navigation Links
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Date:5/26/2010

gressive step to take at this point," said Jeffrey Kindler, Pfizer's chairman and chief executive officer.

The newly named Pfizer Worldwide Research & Development organization will maintain an R&D structure that supports excellence in small molecules, large molecules and vaccine research and development.  It will include biotherapeutics research and development, focused on large molecules and biotechnologies; pharmatherapeutics research and development, focused on small molecules; and vaccines research and development.  Pfizer adopted a novel R&D model following the Wyeth acquisition to foster diversity of talent, assets and culture, as well as the empowerment and accountability of research leaders across R&D.  Pfizer initially implemented this model with a two-division structure (BioTherapeutics and PharmaTherapeutics) to ensure the progress and steady integration of both legacy organizations.  Due to the speed and effectiveness of the integration, Pfizer is now able to implement a diversified R&D platform with the same breadth and research programs, under the consolidated leadership of Dr. Dolsten.

"Mikael Dolsten is an exceptional scientist who is highly regarded and committed to bringing new preventative measures, treatments and cures to people.  Mikael's scientific expertise, vision for R&D and commercial mindset have distinguished him at Pfizer and uniquely qualify him to lead our R&D colleagues and advance our pipeline.  Having all of Pfizer's research conducted under Mikael's leadership will enrich the alignment between our research programs and commercial teams to address important unmet medical needs and deliver the next generation of medicines," said Mr. Kindler.  

"I am excited to have the opportunity to align the tremendous science that is in every corner of Pfizer t
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO ... Martell , to the position of Executive Chairman. Mr. ... Board of Directors. In this new role, he will ... refine and execute on the strategic plan to transition ... for orphan oncology indications with high unmet medical need. ...
(Date:5/28/2015)... FRANCISCO, Calif. , May 28, 2015  CytomX, ... of cancer, today announced that Sean McCarthy , ... upcoming Jefferies 2015 Global Healthcare Conference in ... EDT on Tuesday, June 2, 2015. Dr. McCarthy will ... company,s Precision cancer immunotherapy and Probody drug conjugate programs. ...
(Date:5/28/2015)... SAN DIEGO and CAMBRIDGE, Mass., May 28, ... LLP is investigating whether certain officers ... their fiduciary duties to shareholders.  Eleven Biotherapeutics is ... discovery and development of protein therapeutics to treat ... States .   View this ...
Breaking Medicine Technology:KaloBios Appoints Ronald A. Martell Executive Chairman 2KaloBios Appoints Ronald A. Martell Executive Chairman 3KaloBios Appoints Ronald A. Martell Executive Chairman 4KaloBios Appoints Ronald A. Martell Executive Chairman 5Robbins Arroyo LLP Is Investigating the Officers and Directors of Eleven Biotherapeutics, Inc. (EBIO) on Behalf of Shareholders 2
... 29, 2011 Laboratory Supply Company (LABSCO), the largest ... products to hospitals, physician office laboratories, reference labs and ... to expand its executive leadership team with the new ... financial officer. Willett,s career has included over ...
... SHENZHEN, China, Aug. 29, 2011 /PRNewswire-Asia/ -- Winner ... "Winner Medical" or "the Company"), a leading manufacturer ... made from 100% natural PurCotton® products in China, ... strategic individual investors to establish Shenzhen PurCotton E-Commerce ...
Cached Medicine Technology:LABSCO Hires George Willett as New Vice President and Chief Financial Officer 2Winner Medical's PurCotton E-Commerce Sets Sail 2Winner Medical's PurCotton E-Commerce Sets Sail 3Winner Medical's PurCotton E-Commerce Sets Sail 4
(Date:5/28/2015)... 2015 Medical Device Cybersecurity Quality ... **FDAnews Webinar**, June 23, 2015 — 1:00 p.m. ... Network connectivity opens up a wealth of possibilities ... minefield of potential liabilities. Devices transmit data on ... manufacturers be sure the information doesn’t fall into ...
(Date:5/28/2015)... Angeles, CA (PRWEB) May 28, 2015 ... community of plastic surgeons and patients alike. You can ... surgery, breast augmentation, and body contouring. Readers can directly ... a streamlined user experience from the ground up. , ... is allowing the community to grow and getting ...
(Date:5/28/2015)... AMVETS National Executive Director Stewart Hickey ... Care established by Congress to examine how to best ... to the commission by Mitch McConnell, majority leader of ... only 15 voting members on the panel, which was ... of 2014. The goal of the commission is to ...
(Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will ... honor the strength, passion and endurance of those facing ... of this sunrise-to-sunset event symbolizes the challenging journey of ... raise funds and awareness to advance the care, support ... are encouraged to create their own experience as they ...
(Date:5/28/2015)... Three years ago, Dr. Jeffrey Gosin announced ... Vascular & Vein Center! Dr. Gosin’s center is ... is his mission to provide the highest quality care in ... Dr. Jeffrey Gosin is Board Certified in Surgery and Vascular ... and Jefferson Medical College. He completed a General Surgery residency ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 2Health News:FDAnews Announces — Medical Device Cybersecurity Quality Assurance: Requirements, Best Practices and Innovative Approaches Webinar, June 23, 2015 3Health News:New York Cosmetic Doctors Now in Cosmetic Town 2Health News:New York Cosmetic Doctors Now in Cosmetic Town 3Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3
... expressed concern over the way pregnancy and childbirth in under developed ... and children. // In The World Health Report 2005 released this ... to pregnant women and children till the age of 5 yrs. ... over the world die each year from pregnancy and childbirth related ...
... been a steady rise in diseases caused due to allergens ... ,The researchers have analyzed the blood samples of 513 middle-aged ... the blood samples of the same men from the past ... for the common test against allergens called Phadiatop. The samples ...
... neurological origin. This condition happens when the urge to ... is stationary. The people suffering from the condition suffer ... of something crawling on their legs. These sensations are ... unpleasant to painful. This is also one of the ...
... of US had warned the public and medical ... as atypical antipsychotic drugs on elderly patients with ... clozapine and ziprasidone, are approved for the clinical ... drugs to treat elderly patients with dementia and ...
... team from the University of Western Ontario had found out that ... ,The study used a robot arm to show how ... the video of this learning process was shown to a group, ... the people in the video. Moreover people who learned the same ...
... treating osteoporosis is also able to control the risk// of ... age. ,The study observed women in their postmenopausal life ... for bone fractures due to osteoporosis for three years versus ... women were tested for cognitive impairments like loss of memory ...
Cached Medicine News:
... 3gAllergy: The first FDA-cleared third-generation ... generation of allergy blood testing. It provides ... low levels with excellent precision, accuracy and ... in about an hour to help you ...
... feeder that interfaces with the IMMULITE 2000 and ... the SMS software. Continuous sample loading, onboard sample ... chemistry system racks are just some of the ... affordable solution for improving productivity. The SMS and ...
The 6.5mm cannulated cancellous ACE SCFE Screw is specifically designed for the treatment of slipped capital femoral epiphysis. The ACE SCFE Screw simplifies insertion and facilitates removal....
The DePuy ACE 8.0mm Cannulated Cancellous Screw incorporates TiMAX to provide superior strength, fatigue resistance and a lower modulus of elasticity when compared to similar stainless steel devices....
Medicine Products: